PISCATAWAY, NJ. – Camber Pharmaceuticals has announced the addition of Eszopiclone Tablets, USP to its product line. Eszopiclone Tablets, USP are indicated for the treatment of insomnia. They have been shown to decrease sleep latency and improve sleep maintenance. Between 50 and 70 million Americans suffer from chronic sleep disorders. Sleep deprivation can result in physical and mental health issues, increased risk of injury, reduced productivity, and even a higher chance of mortality.
Eszopiclone Tablets, USP, are available in 1, 2, and 3 mg strengths in 30 and 100 count bottles.
To learn more about Eszopiclone Tablets, USP, please visit https://www.camberpharma.com/eszopiclone.
